Where does Venus Medtech (HANGZHOU), Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Venus Medtech (HANGZHOU), Inc. ranks #6,298 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Venus Medtech (HANGZHOU), Inc. hold?

Venus Medtech (HANGZHOU), Inc. holds 54 US utility patents granted between 2016 and 2025, spanning 9 technology areas.

What is Venus Medtech (HANGZHOU), Inc.'s Innovation Score?

Venus Medtech (HANGZHOU), Inc. has an Innovation Score of 39.9 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Venus Medtech (HANGZHOU), Inc.'s patent grant rate increasing or decreasing?

Venus Medtech (HANGZHOU), Inc.'s recent grant velocity is +48% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Venus Medtech (HANGZHOU), Inc.'s patents?

Venus Medtech (HANGZHOU), Inc.'s patents average 13.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Venus Medtech (HANGZHOU), Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Venus Medtech (HANGZHOU), Inc.

Q: What technology areas does Venus Medtech (HANGZHOU), Inc. focus on?

Venus Medtech (HANGZHOU), Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 48 patents, ranking #125 of 3,082 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 54 granted patents across 9 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Venus ranks #6,298 of 49,997 tracked US assignees by granted-patent volume, with 54 patents across 9 technology areas.

#6,298
of 49,997 US assignees by volume: Top 37%
by Innovation Score (39.9/100): 13.9
avg claims per patent: +48%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6298 · Foreign Corporation #6,298 · 54 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 54 grants
UPPER-Q #6,298/49,997
PHOTO-FINISH Tekni-Plex
CPC-NARROW A61F · 9 areas
INNOV-THIN 39.9/100
CLAIMS-RICH 13.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +48% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tekni-Plex, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Venus’s 39.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.8 pts (35%) Velocity 7.0 pts (18%) Breadth 10.6 pts (27%) Claim depth 8.4 pts (21%)

Qualcomm Incorporated · highest

85
Cathay Biotech · near

40
Sirna Therapeutics · near

40
Topera · near

40
Twistlock · near

40
Venus Medtech… · this assignee

40
3D Lighting… · lowest

7

What this shows Venus's Innovation Score is 39.9/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Venus?

Each dot is one of Venus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Venus’s own 13.9 claims/patent is at or below the 15.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Venus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Venus's grants concentrate

Venus Medtech (HANGZHOU), Inc. is a focused PatentsView assignee: 9 CPC subclasses with 88.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2018 (11 grants) versus a trough of 1 in 2016. By volume, Venus sits between Tekni-Plex, Inc. and Zymogenetics Inc..

Venus's three-year grant acceleration

Venus Medtech (HANGZHOU), Inc. shows 19 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Tekni-plex

54
The Secretary of…

54
Thor Tech

54
Upwing Energy

54
Weir Minerals Aus…

54
Yuhan

54
Zimmer Knee Creat…

54
Zymogenetics

54
Venus Medtech (Ha… ◀

54

What this shows Venus holds 54 patents at rank #6,297, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Venus

By rank, the assignees closest to #6,297 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Venus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Venus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Venus ranks #125 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Sirna Therapeutics, Inc. 40 Topera Inc. 40 Twistlock Ltd. 40 Cathay Biotech Inc. 40

Similar claim depth

Nearest assignees by average claims per patent (13.9 here).

Cnpc USA Corporation 13.9 avg Ansaldo Energia Switzerland AG 13.9 avg Liebherr-werk Nenzing GMBH 13.9 avg The Eastern Company 13.9 avg

Venus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Venus Medtech (HANGZHOU), Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	1.9%
2017	3	5.6%
2018	11	20.4%
2019	6	11.1%
2020	8	14.8%
2021	4	7.4%
2022	6	11.1%
2023	4	7.4%
2024	9	16.7%
2025partial year	2	3.7%

Which technologies does Venus Medtech (HANGZHOU), Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 48

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 9

A61B - DIAGNOSIS; SURGERY; Identification 6

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

Y10T - Technical Subjects Covered BY Former US Classification 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 1

B23P - Metal-working NOT Otherwise Provided FOR; Combined OPERATIONS; Universal Machine Tools 1

F16H - Gearing 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Venus Medtech (HANGZHOU), Inc.'s patent record in context - here's where to go next.

Venus Medtech (HANGZHOU), Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 88.9% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #6,298 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Venus Medtech (HANGZHOU), Inc. against Tekni-Plex, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.